ZERO Prostate Cancer (ZERO), the nation's leading advocacy and support foundation for prostate cancer awareness, has announced the launch of Blitz the Barriers during Cancer Prevention Month. This ...

AAV-Navβ1 gene therapy effectively reduces seizures and prolongs life in a mouse model of SCN1B-linked Dravet syndrome, ...

Biogen ( NASDAQ: BIIB) and Stoke Therapeutics ( NASDAQ: STOK) said on Tuesday they are collaborating to develop and ...

The deal, which features up to $385 million in milestones, gives Biogen exclusive rights to commercialize Stoke’s ...

The partnership splits the rights to Stoke’s epilepsy antisense oligonucleotide, with up to $385 million in potential ...

Biogen receives exclusive rights to commercialize zorevunersen outside U.S., Europe, and Japan.

Biogen has entered a collaboration with Stoke Therapeutics to develop and and commercialise zorevunersen to treat Dravet ...

Don’t be mistaken, despite the album title of Lucky Girl Syndrome, Journey Montana’s position in the music world is a well-earned one. Lucky Girl Syndrome delivers a contemporary blend of pop ...

Here, we speak with Dr Simone Seiter from IMS Health to hear how putting the patient journey at the centre is the key to providing the most accurate market research. Market research has always ...

Biogen Inc. has agreed to pay as much as $550 million to develop and sell a drug to treat a genetic seizure disorder, the ...

The Ballard Clinic sits across the street from the Greyhound bus station in the hollowed-out downtown of Jackson, Tenn., a small city about an hour from Memphis. After Dr. Thomas Ballard III took ...

1. Seek to understand. The patient journey, and the key milestones of that journey, are different for every individual and every disease. These milestones need to be defined at the outset to ...